Ketamine Trial for the Treatment of Depression

This study is a Randomized Controlled Trial, investigating the safety and efficacy of administration of ketamine as a potential treatment for depression.

Topic Depression
Compound Placebo Ketamine
Country Australia
Visit trial
Status Unknown status
Results Published
Start date 03 January 2015
End date 09 January 2015
Chance of happening 0%
Phase Phase I
Design Blinded
Type Interventional
Generation First
Participants 10
Sex All
Age 16- 99
Therapy No

Trial Details

This study is a Randomized Controlled Trial, investigating the safety and efficacy of administration of ketamine as a potential treatment for depression.

NCT Number NCT02401139

Sponsors & Collaborators

The University of New South Wales
This company doesn't have a full profile yet, it is linked to a clinical trial.

University of Sydney
The University of Sydney is Australias oldest university. At the psychopharmacology laboratory, researchers have conducted some research with psychedelics.

Measures Used

Montgomery-Asberg Depression Rating Scale
A ten-item diagnostic questionnaire used to measure the severity of depressive symptoms in patients with mood disorders.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.